Andrée F.
- Country
- Sweden
- Department
- Department of Cardiology
Research Overview
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
Data & Insights
Has run more than one trial at 497 of 1002 partner sites.
Specializations
Cardiovascular Prevention
This investigator specializes in primary prevention strategies for atherosclerotic cardiovascular disease (ASCVD), with particular focus on innovative therapeutic approaches for high-risk patients.
- Preventive Cardiology
- Cardiovascular Risk Management
- Primary Prevention Strategies
The research encompasses evaluation of treatments aimed at reducing cardiovascular events in preventive care settings.
Vascular Medicine
The investigator's work centers on established atherosclerotic cardiovascular disease, focusing on therapeutic interventions for patients with existing vascular conditions.
- Atherosclerosis Management
- Vascular Disease Treatment
- Cardiovascular Outcomes
Their research extends to investigating treatments for reducing major adverse cardiovascular events in patients with established disease.
Clinical Outcomes
The investigator studies major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, and ischemic stroke outcomes.
- Cardiovascular Mortality
- Myocardial Infarction Prevention
- Stroke Prevention
Their work evaluates therapeutic interventions targeting multiple cardiovascular endpoints in clinical settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.